Literature DB >> 20488108

Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance P neuronal systems to stress, in the male rat.

R A Siegel1, E M Düker, E Fuchs, U Pahnke, W Wuttke.   

Abstract

The effects of acute and subchronic stress upon discrete cholecystokinin (CCK) and Substance P (SP) neuronal systems have been studied. Adult male rats were exposed to foot-shock stress for periods of 2, 4, 10, 30 or 60 min, immediately following which they were decapitated; brains were rapidly removed and frozen, and subsequently microdissected and extracted. CCK and SP were determined by RIA. In the olfactory tubercule, stress had no effect upon CCK content, but induced a rapid depletion of SP. In the prefrontal cortex, increased CCK concentrations were found following 30 min of stress exposure. In the medial septum, foot-shock led to a rapid increase in CCK content, and to a similar but delayed change in SP levels. A rapid rise in CCK concentrations was also seen in the lateral septum, but no stress effect whatsoever upon SP occurred in this structure. In the dentate gyrus, CCK exhibited a biphasic responsiveness to stress, while SP levels were increased only at the later time intervals. These data demonstrate that discrete CCK and SP neuronal systems are responsive to stress, and thereby support a functional role for these peptides in the processing of neural and hormonal signals by the CNS.

Entities:  

Year:  1984        PMID: 20488108     DOI: 10.1016/0197-0186(84)90011-1

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

Review 1.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Social defeat increases alcohol preference of C57BL/10 strain mice; effect prevented by a CCKB antagonist.

Authors:  A P Croft; S P Brooks; J Cole; H J Little
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

3.  Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat.

Authors:  C Becker; M H Thièbot; Y Touitou; M Hamon; F Cesselin; J J Benoliel
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

4.  Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.

Authors:  J Harro; M Põld; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

Review 5.  Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders.

Authors:  Sanne M Casello; Rodolfo J Flores; Hector E Yarur; Huikun Wang; Monique Awanyai; Miguel A Arenivar; Rosario B Jaime-Lara; Hector Bravo-Rivera; Hugo A Tejeda
Journal:  Front Neural Circuits       Date:  2022-06-21       Impact factor: 3.342

6.  Cholecystokinin peptides and receptors in the rat brain during stress.

Authors:  J Harro; C Löfberg; J F Rehfeld; L Oreland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

7.  Neurokinin receptor mechanisms in forebrain medial septum modulate nociception in the formalin model of inflammatory pain.

Authors:  Si Yun Ng; Mohammed Zacky Ariffin; Sanjay Khanna
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

8.  Effects of repeated treatment with cholecystokinin sulfated octapeptide on passive avoidance memory under chronic restraint stress in male rats.

Authors:  Malihe Sadeghi; Maryam Radahmadi; Parham Reisi
Journal:  Adv Biomed Res       Date:  2015-07-27

9.  Medial Habenula-Interpeduncular Nucleus Circuit Contributes to Anhedonia-Like Behavior in a Rat Model of Depression.

Authors:  Chunpeng Xu; Yanfei Sun; Xuewei Cai; Tingting You; Hongzhe Zhao; Yang Li; Hua Zhao
Journal:  Front Behav Neurosci       Date:  2018-10-09       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.